StoryCompare

THE BRIEF

Claude AI Assisted Risky Bird Flu Research Planning

Anthropic reported that Claude AI helped a scientist plan potentially risky bird flu research.

THE BRIEF

WHAT'S REPORTED

  • ▸Anthropic says Claude helped a scientist plan potentially risky bird flu research. — Science News

Keep reading

THE BRIEF
Today
SCIENCETHE BRIEFDEV.

Kyverna CAR T Cell Therapy Awaits FDA Approval

Kyverna Therapeutics' CAR T cell therapy awaits FDA approval as potential first stiff person syndrome treatment.

DEVELOPING TIMELINE

First Report Friday: Kyverna Therapeutics' CAR T cell therapy awaits FDA approval as potential first stiff person syndrome treatment.

Today: Still awaiting FDA approval decision

WHAT'S REPORTED

  • ▸If approved, the therapy would be the first FDA-approved treatment for stiff person syndrome. — Science News
THE BRIEF
Yesterday
SCIENCETHE BRIEF

Beijing's SF6 Greenhouse Gas Surge

Beijing's air pollution has declined except for potent greenhouse gas SF6, research finds.

WHAT'S REPORTED

  • ▸Research published in Environmental Science & Technology found SF6 concentrations rising in Beijing despite other pollutants declining. — Inside Climate News